Chang Jae-Hoon
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
- Immune Response and Inflammation
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
- Immunology 46
- Immune Cell Function and Interaction 25
- Immunotherapy and Immune Responses 16
- T-cell and B-cell Immunology 15
-
- NF-κB Signaling Pathways 9
- Co-authors
- Shao‐Cong Sun (12 shared papers)Yichuan Xiao (9 shared papers)Jin Jin (7 shared papers)Xuhong Cheng (8 shared papers)Mikyoung Chang (6 shared papers)Xiaofei Zhou (6 shared papers)Mako Nakaya (2 shared papers)Marzenna Blonska (1 shared paper)
- Journals
- Journal of Controlled Release (6 papers)European Journal of Immunology (5 papers)Nature Immunology (3 papers)The Journal of Immunology (3 papers)Nature Communications (3 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Chang Jae-Hoon
73 papers receiving 3.9k citations
Chang Jae-Hoon's Hit Papers
Peers
Comparison fields: 5 of 114
- Immunology 2.0k
- Cancer Research 707
- Oncology 662
- Biological Psychiatry 56
- Molecular Biology 1.4k
Countries citing papers authored by Chang Jae-Hoon
This map shows the geographic impact of Chang Jae-Hoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Jae-Hoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Jae-Hoon more than expected).
Fields of papers citing papers by Chang Jae-Hoon
This network shows the impact of papers produced by Chang Jae-Hoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Jae-Hoon. The network helps show where Chang Jae-Hoon may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang Jae-Hoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation Hit paper breakdown → | 2014 | 719 |
| 2 | 2013 | 261 | |
| 3 | 2013 | 191 | |
| 4 | 2018 | 174 | |
| 5 | 2013 | 167 | |
| 6 | 2011 | 161 | |
| 7 | 2010 | 146 | |
| 8 | 2010 | 134 | |
| 9 | 2012 | 122 | |
| 10 | 2012 | 118 | |
| 11 | 2018 | 107 | |
| 12 | 2015 | 105 | |
| 13 | 2016 | 96 | |
| 14 | 2009 | 84 | |
| 15 | 2019 | 81 | |
| 16 | 2021 | 75 | |
| 17 | 2013 | 69 | |
| 18 | 2019 | 66 | |
| 19 | 2023 | 56 | |
| 20 | 2014 | 48 |
About Chang Jae-Hoon
Chang Jae-Hoon is a scholar working on Immunology, Cancer Research, Oncology, Molecular Biology and Biomaterials, having authored 76 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), Immunotherapy and Immune Responses (16 papers), T-cell and B-cell Immunology (15 papers), NF-κB Signaling Pathways (9 papers), Nanoplatforms for cancer theranostics (8 papers), Cytokine Signaling Pathways and Interactions (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Immunology (2.0k citations), Cancer Research (707 citations), Oncology (662 citations), Biological Psychiatry (56 citations) and Molecular Biology (1.4k citations). Chang Jae-Hoon has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Shao‐Cong Sun, Yichuan Xiao, Jin Jin, Xuhong Cheng, Mikyoung Chang, Xiaofei Zhou, Mako Nakaya, Marzenna Blonska, Xin Lin and Hongbo Hu. Their work appears in journals such as Journal of Controlled Release, European Journal of Immunology, Nature Immunology, The Journal of Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.